샘플 요청 목록

 카트 문의
시장보고서
상품코드
1763167

세계의 연골 변성 치료 시장

Cartilage Degeneration Therapy
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 194 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 연골 변성 치료 시장은 2030년까지 209억 달러에 달할 전망

2024년에 150억 달러로 추정되는 세계의 연골 변성 치료 시장은 2024-2030년에 CAGR 5.6%로 성장하며, 2030년에는 209억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 관절 치환술은 CAGR 6.3%를 기록하며, 분석 기간 종료시에는 77억 달러에 달할 전망입니다. 연골 형성술 부문의 성장률은 분석 기간에 CAGR 5.9%로 추정됩니다.

미국 시장은 42억 달러로 추정, 중국은 CAGR 5.4%로 성장 예측

미국의 연골 변성 치료 시장은 2024년에 42억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 33억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 5.4%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 5.2%와 4.7%로 예측됩니다. 유럽에서는 독일이 CAGR 5.3%로 성장할 것으로 예측됩니다.

세계의 연골 변성 치료 시장 - 주요 동향과 촉진요인 정리

정형외과에서 연골변성 치료에 대한 수요가 증가하는 이유는 무엇인가?

정형외과에서 연골 퇴행성 치료에 대한 수요가 증가하는 이유는 골관절염, 스포츠 손상, 노화로 인한 연골 마모와 같은 관절 질환의 유병률이 증가하고 있기 때문입니다. 통증, 운동성 저하, 관절 기능 장애로 이어지는 연골 퇴행은 전 세계에서 수백만 명이 앓고 있는 흔한 문제이며, 특히 고령화 인구에서 더욱 그러합니다. 재생의학, 세포치료, 외과적 개입을 포함한 치료법은 관절 기능을 회복하고 통증을 완화하는 해결책을 제시하는 치료법으로 각광받고 있습니다. 인공관절 치환술을 늦추거나 피하기 위한 치료를 찾는 사람들이 늘어나면서 연골 재생 및 보존 치료는 정형외과 치료의 중요한 측면으로 자리 잡고 있습니다.

재생의료의 발전은 연골변성 치료를 어떻게 변화시킬 것인가?

재생의료의 발전은 줄기세포 치료, 혈소판풍부혈장(PRP), 조직공학 등의 혁신적인 솔루션을 제공함으로써 연골 퇴행성 질환 치료 분야에 변화를 가져오고 있습니다. 예를 들어 줄기세포 치료는 간엽줄기세포를 이용해 손상된 연골을 재생시키는 것으로, 기존의 외과적 수술을 대체할 수 있는 저침습적 치료법입니다. 조직공학적인 비계와 바이오소재는 연골의 수리를 지원하고 새로운 조직의 성장을 가속하기 위해 개발되고 있습니다. 이러한 재생 기술의 발전은 근본적인 퇴행에 대처할 뿐만 아니라 장기적인 회복을 촉진하고 환자의 예후를 개선할 수 있는 가능성을 제공함으로써 연골 관련 질환 치료의 판도를 바꾸고 있습니다.

고령화 인구 증가는 연골 퇴행성 질환 치료 시장에서 어떤 역할을 하고 있는가?

노인은 골관절염과 같은 퇴행성 관절 질환에 걸리기 쉽기 때문에 고령화 인구 증가는 연골 퇴행성 질환 치료 시장의 중요한 촉진요인입니다. 평균 수명이 길어짐에 따라 관절 관련 질환의 유병률은 증가할 것으로 예상되며, 관절 기능을 유지하고 삶의 질을 향상시키는 치료법에 대한 수요가 증가할 것으로 예측됩니다. 또한 충격이 큰 스포츠나 신체 활동을 하는 젊은 층도 연골 손상에 대처하는 치료법에 대한 수요가 증가하고 있습니다. 이에 따라 통증을 완화하고 운동 기능을 개선하며 인공관절 치환술의 필요성을 늦추는 치료법이 전 세계 헬스케어 분야에서 각광받고 있습니다.

연골 퇴행성 치료 시장의 성장은 몇 가지 요인에 의해 주도됩니다.

연골 퇴행성 질환 치료 시장의 성장은 골관절염 및 스포츠 관련 부상 발생률 증가, 재생 의학의 발전, 최소 침습적 치료에 대한 관심 증가 등 여러 가지 요인에 의해 주도되고 있습니다. 고령화 사회는 비수술적 치료 옵션에 대한 인식이 높아지면서 관절 건강을 회복할 수 있는 혁신적인 치료법에 대한 수요를 촉진하고 있습니다. 또한 세포 기반 치료, 조직공학, 바이오소재의 기술 발전으로 연골 퇴행성 질환을 앓고 있는 환자들이 이용할 수 있는 치료 옵션의 폭이 넓어지고 있습니다. 효과적인 관절 보존 요법에 대한 수요가 증가함에 따라 연골 퇴행성 질환 치료 시장은 전 세계에서 큰 성장이 예상됩니다.

부문

용도(슬관절, 고관절, 기타 용도), 유형(인공 관절 치환술, 연골 이식술, 골연골 이식술, 미세골절술, 반월판 이식술, 세포 기반 연골 표면 치환술, 자기 연골 세포 이식술, 기타 유형)

조사 대상 기업의 예

  • AlloSource
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • B. Braun SE
  • Ed. Geistlich Sohne AG(Geistlich Group)
  • Huntington Hospital
  • J&J MedTech
  • Smith & Nephew Plc
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc.

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

KSA 25.07.10

Global Cartilage Degeneration Therapy Market to Reach US$20.9 Billion by 2030

The global market for Cartilage Degeneration Therapy estimated at US$15.0 Billion in the year 2024, is expected to reach US$20.9 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Joint Replacements, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$7.7 Billion by the end of the analysis period. Growth in the Chondroplasty segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.2 Billion While China is Forecast to Grow at 5.4% CAGR

The Cartilage Degeneration Therapy market in the U.S. is estimated at US$4.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2030 trailing a CAGR of 5.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.2% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.

Global Cartilage Degeneration Therapy Market - Key Trends & Drivers Summarized

Why Is the Demand for Cartilage Degeneration Therapy Increasing in Orthopedics?

The demand for cartilage degeneration therapy is rising in orthopedics due to the increasing prevalence of joint disorders such as osteoarthritis, sports injuries, and age-related cartilage wear. Cartilage degeneration, which leads to pain, reduced mobility, and joint dysfunction, is a common issue that affects millions worldwide, especially among aging populations. Therapy options, including regenerative medicine, cell-based therapies, and surgical interventions, are gaining traction as they offer solutions to restore joint function and reduce pain. As more people seek treatments to delay or avoid joint replacement surgery, cartilage regeneration and preservation therapies are becoming a crucial aspect of orthopedic care.

How Are Advances in Regenerative Medicine Transforming Cartilage Degeneration Therapy?

Advances in regenerative medicine are transforming the field of cartilage degeneration therapy by providing innovative solutions such as stem cell therapy, platelet-rich plasma (PRP), and tissue engineering. Stem cell therapy, for example, involves the use of mesenchymal stem cells to regenerate damaged cartilage, offering a minimally invasive alternative to traditional surgery. Tissue-engineered scaffolds and biomaterials are being developed to support cartilage repair and encourage the growth of new tissue. These advancements in regenerative techniques not only address the underlying degeneration but also offer the potential to enhance long-term recovery and improve patient outcomes, making them a game-changer in the treatment of cartilage-related disorders.

What Role Does the Growing Aging Population Play in the Cartilage Degeneration Therapy Market?

The growing aging population is a significant driver of the cartilage degeneration therapy market, as elderly individuals are more prone to degenerative joint conditions such as osteoarthritis. As life expectancy increases, the prevalence of joint-related disorders is expected to rise, leading to a higher demand for therapies that can preserve joint function and improve quality of life. Additionally, younger populations engaged in high-impact sports or physical activities are also contributing to the demand for treatments that address cartilage damage. As a result, therapies that provide pain relief, improve mobility, and delay the need for joint replacement are gaining prominence in the global healthcare landscape.

The Growth in the Cartilage Degeneration Therapy Market Is Driven by Several Factors

The growth in the cartilage degeneration therapy market is driven by several factors, including the rising incidence of osteoarthritis and sports-related injuries, advancements in regenerative medicine, and the growing focus on minimally invasive treatments. The aging population, combined with the increased awareness of non-surgical treatment options, is fueling demand for innovative therapies that restore joint health. Technological advancements in cell-based therapies, tissue engineering, and biomaterials are also expanding the range of treatment options available for patients suffering from cartilage degeneration. As the need for effective joint preservation therapies increases, the cartilage degeneration therapy market is expected to experience significant growth globally.

SCOPE OF STUDY:

The report analyzes the Cartilage Degeneration Therapy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Knee, Hip, Other Applications); Type (Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation, Other Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • AlloSource
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • B. Braun SE
  • Ed. Geistlich Sohne AG (Geistlich Group)
  • Huntington Hospital
  • J&J MedTech
  • Smith & Nephew Plc
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Cartilage Degeneration Therapy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Osteoarthritis and Age-Related Joint Disorders
    • Growing Adoption of Regenerative Medicine for Cartilage Degeneration Treatment
    • Technological Advancements in Stem Cell and Platelet-Rich Plasma (PRP) Therapies
    • Rising Demand for Minimally Invasive Cartilage Repair Solutions
    • Expansion of Sports Medicine Driving Demand for Cartilage Restoration Therapies
    • Technological Innovations in Tissue Engineering and Cartilage Scaffolds
    • Increasing Focus on Delaying or Preventing Joint Replacement Surgeries
    • Growing Awareness of Autologous Therapies for Cartilage Repair and Regeneration
    • Rising Adoption of Biologics and Cell-Based Therapies in Orthopedic Care
    • Expansion of Research and Clinical Trials for Advanced Cartilage Degeneration Therapies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cartilage Degeneration Therapy Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cartilage Degeneration Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Cartilage Degeneration Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Joint Replacements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Joint Replacements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Joint Replacements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Chondroplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Chondroplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Chondroplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Osteochondral Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Osteochondral Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Osteochondral Transplants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Microfracture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Microfracture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Microfracture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Meniscus Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Meniscus Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Meniscus Transplants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cell based Cartilage Resurfacing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cell based Cartilage Resurfacing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Cell based Cartilage Resurfacing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Autologus Chondrocyte Implantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Autologus Chondrocyte Implantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Autologus Chondrocyte Implantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Knee by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Knee by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Knee by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Hip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Cartilage Degeneration Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Cartilage Degeneration Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Germany 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Italy 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: UK 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of World 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 110: Rest of World Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of World Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of World 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제